Beacon continues to advance its portfolio. The company’s efforts are supported by funds from Advent Life Sciences, Forbion, Oxford Science Enterprises, Syncona and TCGX. In July 2024, the company ...

Purdue Pharma will pay more than $7 billion for the corporation's role in fueling the opioid epidemic that has killed hundreds of thousands of Americans. The Sackler family and Purdue Pharma reached a ...

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...

NEW DELHI: India is bracing for possible disruptions to its pharmaceutical industry - where the American market accounts for almost a third of exports - during Donald Trump’s presidency.

Laruparetigene zovaparvovec is under clinical development by Beacon Therapeutics and currently in Phase III for Retinitis Pigmentosa ... and a proprietary algorithm to process data points from various ...

Whenever a sunbreak smiles upon Beacon Hill, it’s easy to ignore the roar of Interstate 5 below and jets overhead because this neighborhood’s got something unique in Seattle: a thoroughfare ...

Recursion Pharmaceuticals has a flashy drug development platform. It has a lot to prove about whether that platform's use of AI is helpful. Some power players have backed it with significant ...

HOUSTON and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing therapies for patients with ...